39640-62-5 Usage
General Description
PYRIDINE-4-ACETAMIDE is a chemical compound with the molecular formula C7H8N2O. It is a derivative of pyridine, with an acetamide group attached to the fourth carbon atom in the pyridine ring. PYRIDINE-4-ACETAMIDE is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has also been studied for its potential pharmacological properties, including its use as an anti-inflammatory and analgesic agent. PYRIDINE-4-ACETAMIDE is a solid at room temperature and is soluble in water and organic solvents. It is important to handle and store this compound in a safe manner, following proper chemical safety protocols to avoid any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 39640-62-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,6,4 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 39640-62:
(7*3)+(6*9)+(5*6)+(4*4)+(3*0)+(2*6)+(1*2)=135
135 % 10 = 5
So 39640-62-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O/c8-7(10)5-6-1-3-9-4-2-6/h1-4H,5H2,(H2,8,10)
39640-62-5Relevant articles and documents
Aryl-indolyl maleimides as inhibitors of CaMKIIδ. Part 1: SAR of the aryl region
Levy, Daniel E.,Wang, Dan-Xiong,Lu, Qing,Chen, Zheng,Perumattam, John,Xu, Yong-jin,Liclican, Albert,Higaki, Jeffrey,Dong, Hanmin,Laney, Maureen,Mavunkel, Babu,Dugar, Sundeep
, p. 2390 - 2394 (2008/09/21)
A family of aryl-substituted maleimides was prepared and studied for their activity against calmodulin dependant kinase. Inhibitory activities against the enzyme ranged from 34 nM to >20 μM and were dependant upon both the nature of the aryl group and the hydrogen bond donating potential of the maleimide ring. Key interactions with the kinase ATP site and hinge region were found to be consistent with homology modeling predictions.
11a-Methano-TXA compounds
-
, (2008/06/13)
The present invention provides novel 11a-methano-TXA compounds and intermediates and processs for their preparation. Further provided are methods for using these novel TXA analogs as inhibitors of thromboxane synthetase, rendering these analogs useful for a variety of pharmacological purposes. These pharmacological uses include anti-inflammatory, anti-thromobitc, and anti-asthma indications.
